These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 604101)
21. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718 [TBL] [Abstract][Full Text] [Related]
22. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737 [TBL] [Abstract][Full Text] [Related]
23. Reactogenicity to primary and repeated vaccination with influenza split virus vaccine. Hennessen W; Mauler R; Gruschkau H; Lehmann HG Dev Biol Stand; 1977 Jun 1-3; 39():289-93. PubMed ID: 604110 [TBL] [Abstract][Full Text] [Related]
24. Human responses to purified surface antigen invluenza vaccine (Fluvirin). Stones PB; Furminger IG; Kerr J Dev Biol Stand; 1977 Jun 1-3; 39():239-42. PubMed ID: 604103 [TBL] [Abstract][Full Text] [Related]
25. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis]. Mukhina LP; Bichurina MA; Rozaeva NR Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508 [No Abstract] [Full Text] [Related]
26. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1). Schmidt S; Süss J; Oehring H; Schmidt J Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540 [TBL] [Abstract][Full Text] [Related]
27. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses. Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208 [TBL] [Abstract][Full Text] [Related]
28. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. Cox RJ; Hovden AO; Brokstad KA; Szyszko E; Madhun AS; Haaheim LR Vaccine; 2006 Nov; 24(44-46):6585-7. PubMed ID: 16839650 [TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use. Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505 [TBL] [Abstract][Full Text] [Related]
30. [Safety and immunogenicity of split vaccines of influenza viruses]. Zhu CL; Fang HH; Zhu FC; Wang YQ; Wu XL; Xue FB; Shen YJ; Lian JZ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):207-9. PubMed ID: 15640848 [TBL] [Abstract][Full Text] [Related]
31. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. Neuzil KM; Jackson LA; Nelson J; Klimov A; Cox N; Bridges CB; Dunn J; DeStefano F; Shay D J Infect Dis; 2006 Oct; 194(8):1032-9. PubMed ID: 16991077 [TBL] [Abstract][Full Text] [Related]
32. Inactivated influenza A/New Jersey/76 vaccines in children: results of a mult-center trial. Wright PF; Vaughn WK; Thompson J; Sell SH; Karzon DT Dev Biol Stand; 1977 Jun 1-3; 39():309-13. PubMed ID: 342312 [No Abstract] [Full Text] [Related]
33. Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. Wright PF; Thompson J; Vaughn WK; Folland DS; Sell SH; Karzon DT J Infect Dis; 1977 Dec; 136 Suppl():S731-41. PubMed ID: 606798 [TBL] [Abstract][Full Text] [Related]
34. Viral antigens and impurities in influenza vaccines. Evaluation by immunoelectrophoretic methods. Liehl E; Bachmayer H Dev Biol Stand; 1977 Jun 1-3; 39():163-8. PubMed ID: 564309 [TBL] [Abstract][Full Text] [Related]
35. Antibody response in humans after administration of whole-virion and split vaccine prepared from two different influenza A/swine viruses. Závadová H; Vonka V; Domorázková E; Syrůcek L; Stárek M; Hrusková J; Plesník V; Janout V; Uvízl M J Biol Stand; 1978 Jul; 6(3):173-9. PubMed ID: 721836 [No Abstract] [Full Text] [Related]
36. [Effectiveness of inactivated vaccines against influenza]. Peradze TV; Fridman EA Zh Mikrobiol Epidemiol Immunobiol; 1982 Sep; (9):28-34. PubMed ID: 6755982 [No Abstract] [Full Text] [Related]
38. Reactivity and immunogenicity of monovalent A/New Jersey/76 influenza virus vaccines in children. Lerman SJ J Infect Dis; 1977 Dec; 136 Suppl():S563-70. PubMed ID: 342628 [TBL] [Abstract][Full Text] [Related]
39. From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II. Wright PF; Dolin R; La Montagne JR J Infect Dis; 1976 Dec; 134(6):633-8. PubMed ID: 794423 [TBL] [Abstract][Full Text] [Related]
40. From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration: a status report on national immunization against influenza. Seal JR; Spencer DJ; Meyer HM J Infect Dis; 1976 Jun; 133(6):715-20. PubMed ID: 58953 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]